![Didanosine / Hepatitis / Medicine / Pharmacology / Health / Hepatitis C and HIV co-infection / Emtricitabine/tenofovir/efavirenz / Bristol-Myers Squibb / Protease inhibitors / Hepatitis C Didanosine / Hepatitis / Medicine / Pharmacology / Health / Hepatitis C and HIV co-infection / Emtricitabine/tenofovir/efavirenz / Bristol-Myers Squibb / Protease inhibitors / Hepatitis C](https://www.pdfsearch.io/img/845548c149edf565c1beae591da632d8.jpg)
| Document Date: 2014-10-08 16:23:27 Open Document File Size: 62,93 KBShare Result on Facebook
City PRINCETON / Bristol / / Company Bristol-Myers Squibb / Bristol-Myers Squibb Co. / / Country Japan / United States / / Event FDA Phase / / IndustryTerm treatment of HCV / investigational product / medicinal products / hepatitis C treatment / / MedicalCondition HCV infection / HIV / HCV genotype 3 / hepatitis C. The / hepatitis C / HCV / HCV genotype / / MedicalTreatment liver transplant / / Organization European Union / U.S. Food and Drug Administration / American Association for the Study of Liver Diseases / / Product ribavirin / NS5A / / ProvinceOrState New Jersey / / Technology genotype / /
SocialTag |